TITLE

Therapeutic modification of nuclear factor kappaB binding

AUTHOR(S)
Dunn, Julie A.; Li, Chuanfu
PUB. DATE
December 1997
SOURCE
American Surgeon;Dec1997, Vol. 63 Issue 12, p1036
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Proposes a modification to nuclear factor (NF)-kappaB binding and tumor necrosis factor (TNF)-alpha gene overexpression and evaluate this modification as a possible therapeutic intervention in an animal model of acute pancreatitis. Materials and methods used in the research; Results of the study; Findings and analysis of the results; Conclusions; Commentary of James G. Norman, Jr. on the research procedures and findings.
ACCESSION #
9712124960

 

Related Articles

  • Adalimumab.  // Reactions Weekly;3/26/2011, Issue 1344, p6 

    The article describes the case of a 60-year-old man with a history of Crohn's disease who developed nephrotic syndrome while receiving adalimumab.

  • The Impact of Preoperative Anti-TNF in Surgical and Infectious Complications of Abdominal Procedures for Crohn's Disease: Controversy Still Persists. Kotze, Paulo Gustavo; Coy, Claudio Saddy Rodrigues // American Journal of Gastroenterology;Jan2014, Vol. 109 Issue 1, p139 

    A letter to the editor is presented in response to the article ""Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients" by Ali Syed and colleagues in a 2013 issue of the periodical.

  • Adalimumab.  // Reactions Weekly;9/4/2010, Issue 1317, p9 

    The article describes the case of a 55-year-old woman who was diagnosed with demyelinating encephalomyelitis after taking adalimumab for rheumatoid arthritis.

  • Adalimumab/etanercept/infliximab.  // Reactions Weekly;12/15/2012, Issue 1432, p6 

    The article describes the clinical cases of eight patients who developed vasculitis while under tumor necrosis factor (TNF)-Α inhibitors.

  • Immediate treatment tops monitoring for small HCC.  // PharmacoEconomics & Outcomes News;12/15/2010, Issue 619, p8 

    The article discusses research which compared the cost-effectiveness and survival of patients with hepatocellular carcinoma receiving tumor necrosis factor-alpha converting enzyme (TACE) or radiofrequency ablation (RFA), which references a study by W. E. Naugler and colleagues published in the...

  • Liver enzyme elevations uncommon with TNF-inhibitor use.  // Reactions Weekly;7/10/2010, Issue 1309, p3 

    The article discusses a research study which observed risk of elevated liver enzymes associated with the use of tumour necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis.

  • Adalimumab.  // Reactions Weekly;7/10/2010, Issue 1309, p10 

    The article describes the case of disseminated histoplasmosis in a 21-year-old man with adult-onset Still's disease following adalimumab therapy.

  • Arthritis.  // New Zealand Doctor;4/24/2013, p33 

    The article presents information on a study conducted by Swedish researchers, according to which treatment of rheumatoid arthritis with anti-tumour necrosis factor therapy may carry a small risk of cancerous melanoma.

  • Adalimumab.  // Reactions Weekly;3/26/2011, Issue 1344, p6 

    The article describes the case of a 71-year-old woman with rheumatoid arthritis who developed fatal hepatitis B virus (HBV) reactivation while undergoing adalimumab treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics